Telephone
61.2.9870.7580
Address
7 Eliza Street Newtown, New South Wales (NSW) 2042
Description
Genetic Signatures Ltd. is a research company, which engages in the identification and commercialization of individual genetic signatures for the diagnosis of infectious diseases. It is also involved in the sale of associated products into the diagnostic and research marketplaces. Its products include the treatment for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. It operates in the following geographical segments: Asia Pacific, Europe, Middle East, and Africa (EMEA), and Americas. The company was founded by Robert J. Birrell, Christopher M. Abbott, and Geoffrey Grigg on February 15, 2001 and is headquartered in Newtown, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.38 - 0.85
Trade Value (12mth)
AU$19,089.00
1 week
-1.3%
1 month
7.04%
YTD
87.65%
1 year
18.79%
All time high
2.87
EPS 3 yr Growth
483.500%
EBITDA Margin
-102.50%
Operating Cashflow
-$12m
Free Cash Flow Return
-25.50%
ROIC
-28.80%
Interest Coverage
-17,365.00
Quick Ratio
4.50
Shares on Issue (Fully Dilluted)
144m
HALO Sector
Industrials
Next Company Report Date
28-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
09 July 24 |
Change in substantial holding
×
Change in substantial holding |
08 July 24 |
Application for quotation of securities - GSS
×
Application for quotation of securities - GSS |
08 July 24 |
Change of Director's Interest Notice - T Radford
×
Change of Director's Interest Notice - T Radford |
08 July 24 |
Change of Director's Interest Notice - S Chatonsky
×
Change of Director's Interest Notice - S Chatonsky |
08 July 24 |
Change of Director's Interest Notice - C Waldron
×
Change of Director's Interest Notice - C Waldron |
05 July 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
04 July 24 |
Completion of Underwritten Retail Entitlement Offer
×
Completion of Underwritten Retail Entitlement Offer |
28 June 24 |
Notification of cessation of securities - GSS
×
Notification of cessation of securities - GSS |
26 June 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
17 June 24 |
Change in substantial holding
×
Change in substantial holding |
17 June 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
17 June 24 |
Change in substantial holding
×
Change in substantial holding |
13 June 24 |
Application for quotation of securities - GSS
×
Application for quotation of securities - GSS |
13 June 24 |
Cleansing Notice
×
Cleansing Notice |
12 June 24 |
Despatch Of Retail Entitlement Offer Booklet
×
Despatch Of Retail Entitlement Offer Booklet |
12 June 24 |
Letter To Eligible Retail Shareholders
×
Letter To Eligible Retail Shareholders |
12 June 24 |
Letter To Ineligible Shareholders
×
Letter To Ineligible Shareholders |
06 June 24 |
Completion of Institutional Entitlement Offer and Placement
×
Completion of Institutional Entitlement Offer and Placement |
04 June 24 |
FDA Clearance For Gastrointestinal Parasite Detection Kit
×
FDA Clearance For Gastrointestinal Parasite Detection Kit |
04 June 24 |
Genetic Signatures Appoints Allison Rossiter As CEO
×
Genetic Signatures Appoints Allison Rossiter As CEO |
04 June 24 |
Genetic Signatures Announces $30 Million Capital Raising
×
Genetic Signatures Announces $30 Million Capital Raising |
04 June 24 |
FDA Clearance and Capital Raising Presentation
×
FDA Clearance and Capital Raising Presentation |
04 June 24 |
Entitlement Offer Cleansing Notice
×
Entitlement Offer Cleansing Notice |
04 June 24 |
Proposed issue of securities - GSS
×
Proposed issue of securities - GSS |
04 June 24 |
Proposed issue of securities - GSS
×
Proposed issue of securities - GSS |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.